Akademibokhandeln
Amirhossein Sahebkar, Thozhukat Sathyapalan - Application of Nutraceuticals for the Management of COVID-19, Häftad

Häftad, Engelska, 2045

Application of Nutraceuticals for the Management of COVID-19

Av Amirhossein Sahebkar, Thozhukat Sathyapalan

2429 kr

Kommande

Beskrivning
Application of Nutraceuticals for the Management of COVID-19 provides evidence-based findings in the therapeutic role and mechanisms of phytochemicals for better prevention and treatment of patients with COVID-19. Coverage includes a scientific and evidence-based approach to a wide range of nutraceuticals that have been identified due to their anti-inflammatory and immune system-modulating properties.This is the perfect reference for pharmaceutical researchers with practical ideas for research on the effective therapeutic role of phytochemicals in COVID-19; as well as clinical experts looking to make better decisions in the use of effective supplements for the management of COVID-19.
Produktinformation
  • Utgivningsdatum: 2045-12-31
  • Mått: 191 x 235 x undefined mm
  • Vikt: 450 g
  • Format: Häftad
  • Språk: Engelska
  • Antal sidor: 200
  • Förlag: Elsevier Science Publishing Co Inc
  • ISBN: 9780443220050
Utforska kategorier
Mer information

Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids. Thozhukat Sathyapalan (Sathya) is the academic lead for diabetes, endocrinology, and metabolism research in the Clinical Sciences Centre at the Hull York Medical School. He is also an Honorary Consultant Endocrinologist at Hull and East Yorkshire Hospitals NHS Trust, UK. His main area of research is on modulation of cardiovascular risk through pharmacological and nutritional interventions in insulin resistant states such as obesity, polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus. He is interested in traditional as well as novel risk factors, specifically endocrine disruptors.

Butikslager

Ej i lager i butik.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.